PCMC
GSK icon

Paragon Capital Management (Colorado)’s GSK GSK Stock Holding History

Paragon Capital Management (Colorado)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-560
Closed -$31K – 314
2021
Q4 		$31K Buy
+560
New +$29.1K 0.01% 390
2018
Q1 		– Sell
-5,182
Closed -$230K – 228
2017
Q4 		$230K Hold
5,182
– – 0.09% 151
2017
Q3 		$263K Buy
+5,182
New +$263K 0.1% 141

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Paragon Capital Management (Colorado)'s GSK Position: Q1 2022 in Review

Paragon Capital Management (Colorado) sold out of GSK (GSK) in Q1 2022, closing a stake of 560 shares — an estimated $31K sold.

Paragon Capital Management (Colorado) first reported a position in GSK in Q3 2017 and held it in 3 quarters. The position peaked at $263K in Q3 2017. 929 funds tracked by Wall St. Rank hold GSK as of Q1 2022.

  • Paragon Capital Management (Colorado) reported no remaining GSK position as of Q1 2022 after selling out during the quarter.
  • Paragon Capital Management (Colorado) sold 560 GSK shares in Q1 2022, an estimated $31K.
  • Paragon Capital Management (Colorado) first reported a position in GSK in Q3 2017 and held it in 3 quarters.
  • Paragon Capital Management (Colorado)'s GSK position peaked at $263K in Q3 2017.
  • 929 funds tracked by Wall St. Rank held GSK as of Q1 2022.

Based on Paragon Capital Management (Colorado)'s 13F filing for Q1 2022, filed 19 Apr 2022.